Today: 28 June 2026
Browse Category

NYSE:CAH 30 October 2025 - 6 February 2026

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health shares fell 0.2% to $226.66 Friday morning, despite raising its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share after beating quarterly estimates. Second-quarter revenue rose 19% to $65.6 billion, with adjusted EPS at $2.63. CEO Jason Hollar cited strong specialty medicine demand but downplayed obesity drugs’ profit impact. Cencora rose 0.9%, McKesson slipped 0.4%.
6 February 2026
··
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health shares fell 2.64% to $199.71 on December 3, 2025, marking a fifth straight daily loss and leaving the stock 7% below its November 52-week high. The drop came despite gains in major indices. Recent filings show OMERS and Quantbot Technologies increased their stakes in the company. Cardinal Health has returned 74% over the past year.
4 December 2025
·
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health shares jumped 13% to record highs near $185 after fiscal Q1 2026 results beat estimates, with adjusted EPS at $2.55 and revenue at $64.0 billion. The company raised its full-year outlook and announced a $375 million buyback. All five segments grew profits, marking an eighth straight earnings beat. Cardinal plans to close the Solaris Health acquisition by early November.
30 October 2025
··

Stock Market Today

  • Dow Jones, Nasdaq 100: Four Key Market Movers to Watch This Week
    June 28, 2026, 3:43 PM EDT. Dow Jones and Nasdaq 100 indices slowed recently amid rising stock market volatility. Investors focus on four major events this week. First, US nonfarm payrolls data due, with job growth expected at 114,000 and unemployment steady at 4.3%, influencing Federal Reserve rate decisions. Second, SpaceX could join the Nasdaq 100, triggering a potential $4.3 billion buying spree, though its shares have fallen 32% from highs. Third, fragile US-Iran ceasefire risks geopolitical escalation, which may push crude oil prices higher and unsettle markets. Fourth, key corporate earnings, including Nike, Constellation Brands, and General Mills, will provide fresh insights into market health. These events will shape market direction amid ongoing economic uncertainty.

Latest articles

UiPath (NYSE:PATH) shares see heavy trading after Friday’s jump as buyback calculations come into focus

UiPath (NYSE:PATH) shares see heavy trading after Friday’s jump as buyback calculations come into focus

28 June 2026
UiPath closed up 6.04% at $10.53 Friday, with weekly trading volume equal to 57% of its diluted share count, but shares remain 8.2% below the company’s average first-quarter buyback price of $11.47; with $500 million authorized for repurchases, every $100 million at current prices retires more shares, making buyback efficiency a key factor as revenue and ARR growth remain in the low-teens.
Go toTop